Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Cranfield University
- University of Cambridge
- ; Swansea University
- University of Nottingham
- ; University of Surrey
- The University of Manchester
- ;
- ; Newcastle University
- ; University of Southampton
- AALTO UNIVERSITY
- The University of Manchester;
- University of East Anglia
- University of Newcastle
- ; Brunel University London
- ; King's College London
- ; Manchester Metropolitan University
- ; University of Birmingham
- ; University of Exeter
- ; University of Nottingham
- ; University of Plymouth
- ; University of Sussex
- ; University of Warwick
- Abertay University
- Brunel University
- Durham University;
- King's College London;
- Newcastle University;
- Swansea University
- University of Birmingham
- University of Bristol
- University of Cambridge;
- University of East Anglia;
- University of Exeter
- University of Exeter;
- University of Manchester
- University of Plymouth
- University of Salford;
- University of Sheffield
- University of Sheffield;
- University of Sussex;
- University of Warwick
- 31 more »
- « less
-
Field
-
close to the nest [1 ] but to better understand foraging, we need landscape level detail. The direction of the project can be tailored, but could include developing and applying Bayesian ML approaches
-
health. You will develop and apply cutting-edge machine-learning techniques to identify the most informative indicators of ecosystem change and use them to build dynamic Bayesian network (DBN) ecosystem
-
that target diverse biological processes. These include DNA replication, transcription, translation and cell signaling. To exemplify, nucleoside analogues possess an accomplished history within therapeutic
-
will be grounded in rigorous mathematics coupled with a sound understanding of the underlying earthworm ecology. Bayesian inference methodologies will be developed to estimate where and when behavioural
-
), patent applications and commercialisation (e.g. UoE spinout, MitoRx Therapeutics ). Here, you will design, synthesise and characterise novel potential drug structures to target intracellular structures
-
are suitable. The aims of this project are to Review operating characteristics proposed for rare disease trials Develop novel Bayesian operating characteristics for different types of rare disease trials Apply
-
data. Contribute to the enhancement of the Open Targets Platform to better present psychiatry-relevant omics data and make it more accessible to diverse users. Collaborate with people with lived
-
for health policy decision-making, these methods will be developed using a Bayesian framework. This PhD project will deliver a substantial contribution to original research in the area of health data science
-
interventions. These insights may ultimately lead to the identification of new targets for the development of therapies for ageing and age-related disease. For more information please contact: rebecca.c.taylor
-
://doi.org/10.1172/jci99169 ). However, a host of interconnected metabolic and immune pathways likely regulate tumour progression. Identification of these novel mechanisms will provide new targeted therapeutic